Celltrion selects ‘Oracle’ technology to smoothly manage drug side effects

Oracle announced on the 26^th(U.S. local time) that Celltrion chose ‘Oracle Health Sciences Argus’ and ‘Oracle Health Sciences Empirica Signal’ to launch life-saving chronic disease treatments more and cheaper by controlling side effects and taking actions of safety.

When it comes to this, Sang-Joon Lee, Vice President of Celltrion, said “Since our founding in 2002, we have remained committed t...